IDSA GUIDELINES Bundle (free trial)

Drug-Susceptible Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770889

Contents of this Issue

Navigation

Page 21 of 23

22 Table 10. Suggested Ethambutol Dosages, Using Whole Tablets, for Adults Weighing 40–90 kg a Regimen Weight, kg b,c 40–55 56–75 76–90 Daily (mg/kg ) 800 mg (14.5–20.0) 1200 mg (16.0–21.4) 1600 mg (17.8–21.1) rice weekly (mg/kg ) 1200 mg (21.8–30.0) 2000 mg (26.7–35.7) 2400 mg (26.7–31.6) Twice weekly (mg/kg ) 2000 mg (36.4–50.0) 2800 mg (37.3–50.0) 4000 mg (44.4–52.6) a With normal renal function. b Based on estimated lean body weight. Optimal doses for obese patients are not established. c Numbers in parentheses are the calculated mg/kg doses for patients at the highest and lowest body weights in the weight band. Treatment Grading of Recommendations Assessment, Development, and Evaluation-Based Recommendations Implications for: Strong Recommendation (S) Conditional Recommendation (C) Patients Most individuals in this situation would want the recommended course of action, and only a small proportion would not. e majority of individuals in this situation would want the suggested course of action, but many would not. Clinicians Most individuals should receive the intervention. Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator. Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences. Recognize that different choices will be appropriate for individual patients and that you must help each patient arrive at a management decision consistent with his or her values and preferences. Decision aids may be useful in helping individuals to make decisions consistent with their values and preferences. Policy e recommendation can be adopted as policy in most situations. Policymaking will require substantial debate and involvement of various stakeholders. Certainty in the Evidence High H Low L Moderate M Very Low VL Source: Grading of Recommendations Assessment, Development and Evaluation Working Group (Schunemann HJ et al. Am J Respir Crit Care Med. 2006;174:605–14. Guyatt GH et al. BMJ 2008; 336:924–6).

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Drug-Susceptible Tuberculosis